Troutman Pepper advised Innervace on the deal.Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40 million…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now